This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or building block in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structure, featuring an ethylpiperazine moiety, is often incorporated into compounds designed to interact with neurotransmitter receptors, such as dopamine or serotonin receptors, making it valuable in the development of potential antipsychotic or antidepressant drugs. Additionally, it may be explored in the design of ligands for other therapeutic targets, contributing to drug discovery efforts aimed at treating complex diseases.